openPR Logo
Press release

Type 1 Diabetes Segment to Dominate the United States Insulin Pumps Market | TechSci Research

07-08-2021 07:58 AM CET | Health & Medicine

Press release from: TechSci Research Pvt Ltd

United States Insulin Pumps Market - TechSci Research

United States Insulin Pumps Market - TechSci Research

Increasing demand for minimally invasive treatment and rise in chronic disorders is expected to drive the United States insulin pumps market for the forecast period.

According to TechSci Research report, “United States Insulin Pumps Market By Type (Traditional Insulin Pumps v/s Patch Pumps) By Insulin Used (Short Acting Insulin v/s Rapid Acting Insulin) By Application (Type 1 Diabetes v/s Type 2 Diabetes) By End User (Hospitals & Clinics, Diagnostic Centers, Home Care), By Region, Company Forecast & Opportunities, 2026”, the United States insulin pumps market is expected to witness significant growth for the next five years. Insulin pump are medical devices used to administer the insulin level present in body to control diabetes. Rise in people suffering from diabetes and surge in awareness regarding the benefits of using insulin pumps is a contributing factor expected to strengthen the market. Insulin pumps can be easily controlled by pushing buttons and the biggest advantage of using insulin pumps is that it can be set to deliver insulin with different rates at different time of the day according to the need of the individual. Using insulin pumps is very easy and causes less difficulty while delivering insulin to the human body therefore it provides more flexibility to choose the desired food item without the fear of needles. Rapidly changing lifestyle and consumption of alcohol and smoking causing diabetes is expected to accelerate the demand for insulin pumps. Change in dietary preference coupled with growing preference for packaged food and ready to eat food items containing preservatives and artificial ingredients is affecting the health adversely. Favorable reimbursement policies offered by government to promote healthcare industry is expected to propel the demand of insulin pumps in United States.

The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected several countries adversely. Leading authorities in United States imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. United States authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities. Rise in cases of people suffering from diabetes boosted the sales of insulin pumps. Diabetic people are indulging through various modes such as hospital pharmacies, medical shops and through online channels to buy critical medical devices.

However, side-effects of insulin pumps such as skin infections and high cost of insulin pumps may create hindrance in the growth of the insulin pumps market.

Browse XX Figures spread through XX Pages and an in-depth TOC on "United States Insulin Pumps Market”.
https://www.techsciresearch.com/report/united-states-insulin-pumps-market/7589.html

United States insulin pumps market is segmented into type, insulin used, application, end user, regional distribution, and company. Based on type, market can be divided into traditional insulin pumps and patch pumps. The traditional insulin pumps type segment is expected to account for major market share for the forecast period, 2022-2026. These are readily available in the market and highly reliable in nature. Based on application, market can be divided into type 1 diabetes and type 2 diabetes. The type 1 diabetes application segment is expected to dominate the market for the next five years due to rising prevalence of type 1 diabetes. Patients suffering from type 1 diabetes are not able to produce insulin in their body by themselves therefore need for insulin pumps is highest for this segment.

Medtronic USA, Inc, Roche Diagnostics Corporation, Becton, Dickinson and Company, B. Braun Medical Inc., Abbott Laboratories, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Nipro Medical Corporation are the leading players operating in United States insulin pumps market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several insulin pumps manufacturers are coming up with their technologically advanced offerings.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7589
Customers can also request for 10% free customization on this report.

“Market players are focusing on research and development activities to advance the existing infrastructure of insulin pumps and develop new generation insulin pumps. These new generation insulin pumps are safe, convenient, provide precise results and the integration with digital technology enables patient to address the health-related issues remotely and share the patient’s data for proper treatment. Home infusion therapy and artificial pancreas are some of the technological advancements which is expected to fuel the demand for insulin pumps in United States. Adoption of smart technologies such as artificial intelligence and machine learning can improve the performance of insulin pumps and prevent the need for rapid re-adjustments which is expected to propel the demand for insulin pump till 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“United States Insulin Pumps Market By Type (Traditional Insulin Pumps v/s Patch Pumps) By Insulin Used (Short Acting Insulin v/s Rapid Acting Insulin) By Application (Type 1 Diabetes v/s Type 2 Diabetes) By End User (Hospitals & Clinics, Diagnostic Centers, Home Care), By Region, Company Forecast & Opportunities, 2026” has evaluated the future growth potential of United States insulin pumps market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of United States insulin pumps market.

Browse Related Reports:
United States Human Insulin Market By Indication (Type 1 Diabetes v/s Type 2 Diabetes) By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection) By Type (Basal, Bolus, Pre-Mixed, Biosimilar, Traditional) By Onset Time (Rapid Acting, Short Acting, Intermediate Acting, Long Lasting, Others) By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Others) By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/united-states-human-insulin-market/7554.html

Global Human Insulin Market By Indication (Type I Diabetes, Type II Diabetes), By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration (Subcutaneous, Transdermal, Nasal, Intravenous, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid acting, Short-acting, Intermediate acting, Long acting, Pre-Mixed, Inhaled, Ultra-long Acting), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injections), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/human-insulin-market/4637.html

About TechSci Reseach:
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Type 1 Diabetes Segment to Dominate the United States Insulin Pumps Market | TechSci Research here

News-ID: 2323775 • Views:

More Releases from TechSci Research Pvt Ltd

India AI in Medical Diagnostics Market Future Outlook (2024-2030)
India AI in Medical Diagnostics Market Future Outlook (2024-2030)
India AI in Medical Diagnostics Market Outlook The India AI in Medical Diagnostics Market, valued at USD 12.87 million in 2024, is poised for significant growth, with a projected compound annual growth rate (CAGR) of 23.10% from 2020 to 2030, reaching an estimated USD 44.87 million by 2030. This robust expansion is driven by the increasing adoption of artificial intelligence (AI) solutions in healthcare, a rising demand for early and accurate
The Future of Robotic Healthcare Market in India
The Future of Robotic Healthcare Market in India
India Surgical Robotics Market Outlook The India Surgical Robotics Market, valued at USD 24.72 million in 2024, is on a trajectory of significant growth, projected to reach USD 44.91 million by 2030, driven by a robust compound annual growth rate (CAGR) of 10.42%. This expansion is underpinned by a confluence of factors, including the rising demand for minimally invasive surgeries, advancements in robotic technologies, and the rapid development of healthcare infrastructure
India Medical Lasers Market: Growth, Trends, and Challenges (2020-2030)
India Medical Lasers Market: Growth, Trends, and Challenges (2020-2030)
The India Medical Lasers Market is poised for significant growth, projected to expand at a compound annual growth rate (CAGR) of 12.90%, rising from USD 31.20 million in 2024 to USD 64.75 million by 2030. This robust growth is driven by increasing demand for minimally invasive procedures, a rising prevalence of chronic diseases, and supportive government initiatives such as Ayushman Bharat and Make in India. These programs are enhancing healthcare
India Pneumococcal Vaccine Market Report Outlook 2030 by TechSci Research
India Pneumococcal Vaccine Market Report Outlook 2030 by TechSci Research
Market Outlook: India Pneumococcal Vaccine Market The India pneumococcal vaccine market is projected to grow from USD 32.52 million in 2024 to USD 48.67 million by 2030, reflecting a CAGR of 6.91%. Growth is being driven by strong government initiatives, such as the inclusion of the Pneumococcal Conjugate Vaccine (PCV) in the Universal Immunization Programme (UIP), rising awareness about pneumonia-related mortality-especially in children-and enhanced local production by domestic manufacturers. Support from international

All 5 Releases


More Releases for Insulin

Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin